News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Photo collage of Laura Bukavina and Phillip Abbosh
Jul 4, 2024, 13:06

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:

“The NTACT residual disease test, eloquently presented by Phillip Abbosh published in JCO Precision Oncology. Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT cancer. NTACT demonstrated 91% sensitivity and 82% accuracy.”

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Read further.
Source: Laura Bukavina/X

cancer cancer mutations Cleveland Clinic field cancerization JCO Precision Oncology Laura Bukavina NTACT OncoDaily Oncology oncology research Phillip Abbosh Precision Medicine residual disease test Urologic Oncologist
Special Coverage
Voices
Aug 24, 2025, 01:32
Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study
Insight
Aug 24, 2025, 01:13
Discovering Approaches to Enhance CAR-NK Cell Antitumor Activity with CRISPR - MD Anderson Cancer Center
Voices
Aug 23, 2025, 23:27
Lauren Kriger Groner: Filming the Cracking Cancer Podcast with The White Ribbon Project
Voices
Aug 23, 2025, 22:57
Paolo Tarantino: Exploring IO and ADC Combinations at SITC25
Drugs
Aug 23, 2025, 22:35
LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen
Voices
Aug 23, 2025, 22:10
Neeraj Agarwal: USPCCC 2025 with Alan H Bryce's Introductory Remarks
Voices
Aug 23, 2025, 21:58
Al-Ola A Abdallah: Reducing Platelet Transfusion Threshold Before LP in Hematologic Malignancy Patients
Voices
Aug 23, 2025, 21:42
Nina Niu Sanford: NRG-GI011 Has Enrolled and Randomized Its 1st Patient
Voices
Aug 23, 2025, 21:31
Rahul Banerjee Shared NEJM Study on Targeted Therapy of CAR+ T-Cell Lymphoma
Societies
Aug 23, 2025, 20:55
Advancing Cancer Treatment with Therapeutic Vaccines - MSKCC
Voices
Aug 23, 2025, 20:22
Joe Taylor's Last Week in the Lab at Fred Hutch Cancer Center - Hsieh Lab
Voices
Aug 23, 2025, 20:12
Sameer Keole Previews ASTRO25: Rediscovering Radiation Medicine and Exploring New Indications